Q1 2018 13F Holders as of 3/31/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.9M
-
Number of holders
-
321
-
Total 13F shares, excl. options
-
70.2M
-
Shares change
-
+583K
-
Total reported value, excl. options
-
$6.2B
-
Value change
-
+$35.3M
-
Number of buys
-
151
-
Number of sells
-
-146
-
Price
-
$88.29
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q1 2018
366 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q1 2018.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 321 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70.2M shares
of 71.9M outstanding shares and own 97.64% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (9.71M shares), VANGUARD GROUP INC (6.82M shares), BlackRock Inc. (6.48M shares), FRANKLIN RESOURCES INC (3.9M shares), Neuberger Berman Group LLC (3.17M shares), ALLIANCEBERNSTEIN L.P. (2.66M shares), STATE STREET CORP (2.4M shares), Select Equity Group, L.P. (1.9M shares), JPMORGAN CHASE & CO (1.85M shares), and BAMCO INC /NY/ (1.71M shares).
This table shows the top 321 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.